[go: up one dir, main page]

CN1950092A - 对延长的激素避孕方案中突破性出血的控制 - Google Patents

对延长的激素避孕方案中突破性出血的控制 Download PDF

Info

Publication number
CN1950092A
CN1950092A CNA200580013899XA CN200580013899A CN1950092A CN 1950092 A CN1950092 A CN 1950092A CN A200580013899X A CNA200580013899X A CN A200580013899XA CN 200580013899 A CN200580013899 A CN 200580013899A CN 1950092 A CN1950092 A CN 1950092A
Authority
CN
China
Prior art keywords
days
day
amount
cycle
progestogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA200580013899XA
Other languages
English (en)
Chinese (zh)
Inventor
安德烈亚斯·萨克塞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Priority to CN201711247393.6A priority Critical patent/CN107875388A/zh
Publication of CN1950092A publication Critical patent/CN1950092A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
CNA200580013899XA 2004-04-30 2005-04-29 对延长的激素避孕方案中突破性出血的控制 Pending CN1950092A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711247393.6A CN107875388A (zh) 2004-04-30 2005-04-29 对延长的激素避孕方案中突破性出血的控制

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US56644304P 2004-04-30 2004-04-30
US60/566,443 2004-04-30
US60/575,024 2004-05-28
US60/577,199 2004-06-07
US60/638,380 2004-12-27
US60/660,068 2005-03-10

Related Child Applications (2)

Application Number Title Priority Date Filing Date
CN201711247393.6A Division CN107875388A (zh) 2004-04-30 2005-04-29 对延长的激素避孕方案中突破性出血的控制
CN2012105794658A Division CN103127156A (zh) 2004-04-30 2005-04-29 对延长的激素避孕方案中突破性出血的控制

Publications (1)

Publication Number Publication Date
CN1950092A true CN1950092A (zh) 2007-04-18

Family

ID=38019305

Family Applications (2)

Application Number Title Priority Date Filing Date
CNA200580013899XA Pending CN1950092A (zh) 2004-04-30 2005-04-29 对延长的激素避孕方案中突破性出血的控制
CN201711247393.6A Pending CN107875388A (zh) 2004-04-30 2005-04-29 对延长的激素避孕方案中突破性出血的控制

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201711247393.6A Pending CN107875388A (zh) 2004-04-30 2005-04-29 对延长的激素避孕方案中突破性出血的控制

Country Status (4)

Country Link
CN (2) CN1950092A (ru)
GT (1) GT200500099A (ru)
UA (1) UA91190C2 (ru)
ZA (1) ZA200609988B (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108025014A (zh) * 2015-06-23 2018-05-11 莱昂实验室制药股份有限公司 用于过重女性患者的基于屈螺酮的避孕药

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108025014A (zh) * 2015-06-23 2018-05-11 莱昂实验室制药股份有限公司 用于过重女性患者的基于屈螺酮的避孕药
CN108025014B (zh) * 2015-06-23 2021-10-22 莱昂实验室制药股份有限公司 用于过重女性患者的基于屈螺酮的避孕药

Also Published As

Publication number Publication date
GT200500099A (es) 2006-05-05
UA91190C2 (ru) 2010-07-12
CN107875388A (zh) 2018-04-06
ZA200609988B (en) 2008-07-30

Similar Documents

Publication Publication Date Title
AU2005237255B2 (en) Management of breakthrough bleeding in extended hormonal contraceptive regimens
US8063030B2 (en) Extended cycle multiphasic oral contraceptive method
CN1137691C (zh) 基于天然雌激素的多相避孕制剂
CN1142185A (zh) 避孕组合物
JPH04290830A (ja) 避妊薬処方物
JP2007512291A (ja) ２種のエストロゲン及び／又はプロゲスチン組成物を含んで成る、２１〜２８日よりも長い期間にわたっての連続ホルモン処理のための医薬製剤
CN1211087C (zh) 用于适应需要的女性生育节制的竞争性黄体酮拮抗剂
US20060079491A1 (en) Method of female hormonal contraception using a fixed extended cycle hormonal preparation containing dienogest and ethinyl estradiol
CN1950092A (zh) 对延长的激素避孕方案中突破性出血的控制
AU2011226911B2 (en) Management of breakthrough bleeding in extended hormonal contraceptive regimens
HK1102771A (en) Management of breakthrough bleeding in extended hormonal contraceptive regimens
HK1246664A1 (en) Management of breakthrough bleeding in extended hormonal contraceptive regimens
HK1186108A (en) Management of breakthrough bleeding in extended hormonal contraceptive regimens

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1102771

Country of ref document: HK

ASS Succession or assignment of patent right

Owner name: BAYER INTELLECTUAL PROPERTY GMBH

Free format text: FORMER OWNER: BAYER PHARMA AG

Effective date: 20130724

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20130724

Address after: German Monheim

Applicant after: Bayer Pharma Aktiengesellschaft

Address before: Berlin

Applicant before: Bayer Pharma AG

CB03 Change of inventor or designer information

Inventor after: Sachse Andreas

Inventor after: P J Sura grams

Inventor before: Sachse Andreas

CB03 Change of inventor or designer information
RJ01 Rejection of invention patent application after publication

Application publication date: 20070418

RJ01 Rejection of invention patent application after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1102771

Country of ref document: HK